Search for Clinical Trial Results

Adenocarcinoma, Clear Cell - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium Condition:
|
Recruiting |
Study Name: A Study of ENMD-2076 in Ovarian Clear Cell Cancers Condition: Ovarian Clear Cell Carcinoma Date: 2013-07-11 Interventions: Drug: ENMD-2076 |
Recruiting |
Study Name: Immunochemotherapy for Metastatic Renal Cell Carcinoma Condition: Adenocarcinoma Clear Cell Date: 2005-09-26 Interventions: Drug: Capecitabine (Xeloda) |
Recruiting |
Study Name: Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma Condition:
Date: 2013-03-19 Interventions: Drug: Sunitinib 37.5mg everyday from D1-D28 Other Na |
Completed |
Study Name: Ovarian Clear Cell Adenocarcinoma Review Condition: [M]Ovarian Cystadenoma or Carcinoma Date: 2009-01-04 |
Recruiting |
Study Name: MEDI4736 Combinations in Metastatic Renal Cell Carcinoma Condition:
Date: 2016-02-22 Interventions: |
Completed |
Study Name: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer Condition:
|
Active, not recruiting |
Study Name: Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition:
|
Active, not recruiting |
Study Name: Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer Condition:
|
Completed |
Study Name: AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib Condition: Advanced Renal Cell Carcinoma Date: 2007-04-26 Interventions:
|